Article Details

The High-Stakes Race for HAE: Ionis Pharmaceuticals and the Promise of Donidalorsen

Retrieved on: 2025-08-21 17:49:49

Tags for this article:

Click the tags to see associated articles and topics

The High-Stakes Race for HAE: Ionis Pharmaceuticals and the Promise of Donidalorsen. View article details on hiswai:

Excerpt

... monoclonal antibodies—offering limited durability, frequent dosing, or invasive administration. The HAE market is projected to grow from $3.13 ...

Article found on: www.ainvest.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo